Back to All Events

Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee

The Committee reviewed and discussed a list of molecular targets for which evidence and/or biologic rationale exist to determine their potential relevance to the growth or progression of one or more pediatric cancers and a list of those targets deemed unlikely to be associated with the growth or progression of pediatric tumors. Federal Register Notice